ELF5 is an epithelial-specific ETS transcription factor that functions as a master regulator of cell fate and tissue homeostasis. ELF5 binds DNA sequences containing the consensus core GGA[AT] and transcriptionally activates target genes including SPRR2A and gland-specific promoters 1. ELF5 is essential for early embryogenesis, with null mutations causing lethality before embryonic day 7.5, and is critically required for mammary gland development during pregnancy and lactation through regulation of milk protein expression 2. The protein functions as a gatekeeper in developmental hierarchies, integrating hormonal and growth factor signaling to specify epithelial cell identity, particularly in luminal adaptive secretory progenitor (LASP) cells of breast tissue 34. In cancer biology, ELF5 loss represents a key epigenetic alteration associated with tumorigenesis; reduced ELF5 accessibility and expression in BRCA1 heterozygous mammary epithelial cells promotes early breast cancer onset through altered chr11 accessibility 5. ELF5 dysregulation correlates with tamoxifen resistance in ER-positive breast cancers, with altered methylation patterns predicting clinical progression 6. Genome-wide association studies have identified ELF5 variants as risk loci for COVID-19 severity and lung adenocarcinoma, particularly in East Asian populations 78. These findings establish ELF5 as both a developmental master regulator and an important player in epithelial cancer progression.